<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03991507</url>
  </required_header>
  <id_info>
    <org_study_id>RMCZZU-PCOS cohort study</org_study_id>
    <nct_id>NCT03991507</nct_id>
  </id_info>
  <brief_title>PCOS (Polycystic Ovarian Syndrome) Patients</brief_title>
  <official_title>Prospective Cohort Study for PCOS Patients in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Zhengzhou University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Prospective Cohort Study for PCOS Patients was set up to investigate the short- and
      long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of
      Zhengzhou University, China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polycystic ovary syndrome (PCOS) affects 8-13% of women. It is a multifaceted condition
      characterized by chronic anovulation and excess ovarian activity.

      Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record
      Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated
      Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and
      Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded
      comprehensively. The current project plans to recruit PCOS participants in our center.
      Biological samples, questionnaires and short/long term health data will be collected. The
      study is aimed to provide evidence for PCOS prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Anticipated">December 31, 2050</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2050</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Level of serum FSH (Follicle stimulating hormone)</measure>
    <time_frame>From date of inclusion, assessed by each 12 month, up to 40 years</time_frame>
    <description>mIU/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of serum LH (Luteinizing hormone)</measure>
    <time_frame>From date of inclusion, assessed by each 12 month, up to 40 years</time_frame>
    <description>mIU/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of T (Testosterone)</measure>
    <time_frame>From date of inclusion, assessed by each 12 month, up to 40 years</time_frame>
    <description>ng/ml</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Weight</measure>
    <time_frame>From date of inclusion, assessed by each 12 month, up to 40 years</time_frame>
    <description>Recorded in Kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>From date of inclusion, assessed by each 12 month, up to 40 years</time_frame>
    <description>Recorded in centimeters</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Health Related</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        PCOS patients diagnosed with The Rotterdam diagnostic criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCOS patients diagnosed with The Rotterdam diagnostic criteria.

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lanlan Fang, M.D.</last_name>
    <phone>13673355291</phone>
    <email>fanglly@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450052</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiqin Bu, M.D.</last_name>
      <phone>15981978863</phone>
      <email>rmczzu@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2019</study_first_posted>
  <last_update_submitted>June 18, 2019</last_update_submitted>
  <last_update_submitted_qc>June 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Zhengzhou University</investigator_affiliation>
    <investigator_full_name>Yingpu Sun</investigator_full_name>
    <investigator_title>Director of Reproductive Medical Center</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

